{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:40:09Z","timestamp":1790894409917,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12969-017-0178-9","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T09:13:11Z","timestamp":1497431591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia"],"prefix":"10.1186","volume":"15","author":[{"given":"Ekaterina I.","family":"Alexeeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla S.","family":"Namazova-Baranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana M.","family":"Bzarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniya I.","family":"Valieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina V.","family":"Denisova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana V.","family":"Sleptsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniya B.","family":"Isaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Chomahidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay I.","family":"Taibulatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna N.","family":"Fetisova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Karaseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr A.","family":"Baranov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"key":"178_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1546-0096-6-11","volume":"6","author":"S Prahalad","year":"2008","unstructured":"Prahalad S, Glass DN. A comprehensive review of the genetics of juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2008;6:11.","journal-title":"Pediatr Rheumatol Online J"},{"key":"178_CR2","first-page":"264","volume":"69","author":"P Kahn","year":"2011","unstructured":"Kahn P. Juvenile idiopathic arthritis - an update on pharmacotherapy. Bull NYU Hosp Jt Dis. 2011;69:264\u201376.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"178_CR3","unstructured":"Overall incidence in children in Russia (under age of 14 years) in 2011. Report of the Russian Federation Ministry of Health; 2015. \nhttps:\/\/static-3.rosminzdrav.ru\/system\/attachments\/attaches\/000\/015\/822\/original\/ZD6.DOC?1389768574\n\n."},{"key":"178_CR4","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Weiss PF, Beukelman T, DeWitt EM, Ilowite NT, Kimura Y, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum. 2013;65:2499\u2013512.","journal-title":"Arthritis Rheum"},{"key":"178_CR5","doi-asserted-by":"publisher","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63(4):465\u201382. doi:\n10.1002\/acr.20460\n\n.","DOI":"10.1002\/acr.20460"},{"key":"178_CR6","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2011.1671","volume":"306","author":"MH Otten","year":"2011","unstructured":"Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, et al. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA. 2011;306:2340\u20137.","journal-title":"JAMA"},{"issue":"9","key":"178_CR7","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","volume":"60","author":"EH Giannini","year":"2009","unstructured":"Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, et al. Pediatric Rheumatology Collaborative Study Group. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(9):2794\u2013804.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"178_CR8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10067-014-2744-6","volume":"34","author":"D Windschall","year":"2015","unstructured":"Windschall D, M\u00fcller T, Becker I, Horneff G. Safety and efficacy of etanercept in children with the JIA categories extended oligoarthritis, enthesitis-related arthritis and psoriasis arthritis. Clin Rheumatol. 2015;34(1):61\u20139.","journal-title":"Clin Rheumatol"},{"key":"178_CR9","doi-asserted-by":"crossref","unstructured":"Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, et al. Paediatric Rheumatology International Trials Organisation (PRINTO). Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. Ann Rheum Dis. 2014;73(6):1114\u201322.","DOI":"10.1136\/annrheumdis-2012-203046"},{"key":"178_CR10","doi-asserted-by":"crossref","unstructured":"Verazza S, Dav\u00ec S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, et al. Italian Pediatric Rheumatology Study Group.. Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept. Pediatr Rheumatol Online J. 2016;14(1):68.","DOI":"10.1186\/s12969-016-0126-0"},{"key":"178_CR11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/rheumatology\/kev434","volume":"55","author":"L Kearsley-Fleet","year":"2016","unstructured":"Kearsley-Fleet L, Davies R, Lunt M, Southwood TR, Hyrich KL. Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Rheumatology (Oxford). 2016;55:840\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"178_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3899\/jrheum.120842","volume":"40","author":"N Solari","year":"2013","unstructured":"Solari N, Palmisani E, Consolaro A, Pistorio A, Viola S, Buoncompagni A, et al. Factors associated with achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept. J Rheumatol. 2013;40:192\u2013200.","journal-title":"J Rheumatol"},{"key":"178_CR13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/rheumatology\/ket490","volume":"53","author":"T Geikowski","year":"2014","unstructured":"Geikowski T, Becker I, Horneff G, German BIKER Registry Collaborative Study Group. Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis. Rheumatology (Oxford). 2014;53:1245\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"178_CR14","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"178_CR15","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/art.34373","volume":"64","author":"A Consolaro","year":"2012","unstructured":"Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C, et al. Paediatric Rheumatology International Trials Organization. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis Rheum. 2012;64:2366\u201374.","journal-title":"Arthritis Rheum"},{"key":"178_CR16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.20497","volume":"63","author":"CA Wallace","year":"2011","unstructured":"Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N, Childhood Arthritis Rheumatology Research Alliance, et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63:929\u201336.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"178_CR17","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1136\/annrheumdis-2014-205265","volume":"74","author":"EH Dijkhuizen van","year":"2015","unstructured":"van Dijkhuizen EH, Wulffraat NM. Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review. Ann Rheum Dis. 2015;74:1996\u20132005.","journal-title":"Ann Rheum Dis"},{"key":"178_CR18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum. 2003;48:1093\u2013101.","journal-title":"Arthritis Rheum"},{"key":"178_CR19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10067-011-1720-7","volume":"30","author":"EI Alexeeva","year":"2011","unstructured":"Alexeeva EI, Valieva SI, Bzarova TM, Semikina EL, Isaeva KB, Lisitsyn AO, et al. Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis. Clin Rheumatol. 2011;30:1163\u201372.","journal-title":"Clin Rheumatol"},{"key":"178_CR20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/keq292","volume":"50","author":"V Papsdorf","year":"2011","unstructured":"Papsdorf V, Horneff G. Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis. Rheumatology (Oxford). 2011;50:214\u201321.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"178_CR21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/acr.22613","volume":"67","author":"I Foeldvari","year":"2015","unstructured":"Foeldvari I, Becker I, Horneff G. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry. Arthritis Care Res (Hoboken). 2015;67(11):1529\u201335.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-017-0178-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T09:13:43Z","timestamp":1497431623000},"score":1,"resource":{"primary":{"URL":"http:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-017-0178-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,14]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1186\/s12969-017-0178-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,14]]},"article-number":"51"}}